Completed
PHASE4
INTERVENTIONAL
NCT02185326
Microflare Protocol in Poor Responders
View on ClinicalTrials.gov
Updated Dec 15, 2025
Brief Summary
The effect of use of the microflare down regulation protocol on the outcome of the IVF/ICSI cycles in poor responders
Detailed Description
The microflare as a method of down regulation protocol can be used to prepare the females suffering from poor ovarian reserve to undergo IVF/ICSI cycles. In this study we are trying to outline its effect on the clinical pregnancy rate as a main primary outcome, and to compare its use with the addition of growth hormone to the same protocol.
Interventions
Name:
Growth hormone (Norditropin, Novo nordisk)
Type:
DRUG
Description:
Growth hormone (Norditropin, Novo nordisk) was administrated on day 6 of HMG stimulation daily in a dose of 2.5 mg S.C. till the day of hCG administration.
Primary Outcomes
Measure:
Clinical pregnancy rates
TimeFrame:
15 months
Description:
Trial Information
NCT ID
NCT02185326
Status
Completed
Study Type
INTERVENTIONAL
Phases
PHASE4
Sponsor
Woman's Health University Hospital, Egypt
Last Updated
December 15, 2025